After several recent verdicts against Risperdal maker Johnson & Johnson (J&J), the future looks very promising for the roughly 1,600 cases that are still pending against the company in Philadelphia. In February, 2015, a jury handed a verdict to a plaintiff who suffered Risperdal injuries. Two more victories followed before the end of the year. If you or your son developed male breasts after taking Risperdal (risperidone) you may be entitled to substantial compensation for your injuries, as well.
Misleading and Off-label Marketing
The jury that delivered the most recent verdict for a Risperdal victim, in December, 2015, found that Risperdal caused male breast growth and that the drug maker had failed to warn doctors and consumers about the potential side effects.
Also in December, J&J agreed to pay $15.5 million in a settlement with the Kentucky Attorney General. The lawsuit alleged that J&J and its subsidiary Janssen marketed Risperdal off-label while hiding some of the potential side effects from patients. Off-label marketing is marketing a drug for a purpose or purposes other than what it has been specifically approved for by the U.S. Food and Drug Administration (FDA).
If You Have Been Harmed by Risperdal
Risperdal has been found to cause gynecomastia. Gynecomastia can be corrected surgically, but the emotional damage for those who develop the condition as boys and young men can be devastating and irreversible. An experienced defective drug attorney can help you recover the compensation you deserve for your injuries.
If you have been harmed by Risperal, please talk to an experienced defective drug attorney right away to learn more about your rights.